Options: Hide MedDRA Preferred Terms , display all 39 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angina unstable | x | ||||||||||||||||||||||
| Arrhythmia | x | ||||||||||||||||||||||
| Atrial pressure | x | ||||||||||||||||||||||
| Cardiac failure | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Cardiac failure chronic | x | ||||||||||||||||||||||
| Cardiac failure congestive | x | x | x | ||||||||||||||||||||
| Cerebrovascular accident | x | ||||||||||||||||||||||
| Drug interaction | x | ||||||||||||||||||||||
| Essential hypertension | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
| Hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Hypertensive | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Ischaemic cardiomyopathy | x | ||||||||||||||||||||||
| Left ventricular dysfunction | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
| Myocardial infarction | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Non-ischemic cardiomyopathy | x | ||||||||||||||||||||||
| Prostatism | x | ||||||||||||||||||||||
| Reflex tachycardia | x | ||||||||||||||||||||||
| Renal vessel disorder | x | x | |||||||||||||||||||||
| Vascular resistance systemic | x | ||||||||||||||||||||||
| Vasodilation | x | ||||||||||||||||||||||
| Ventricular dysfunction | x | x | |||||||||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |